Nombre del producto:sodium;7-phenyl-5-(4-sulfonatoanilino)benzo[a]phenazin-7-ium-3-sulfonate

IUPAC Name:10-phenyl-12-[(4-sulfonatophenyl)amino]-5,10λ⁵-diazatetraphen-10-ylium-2-sulfonate sodium

CAS:25641-18-3
Fórmula molecular:C28H18N3NaO6S2
Pureza:95%+
Número de catálogo:CM693660
Peso molecular:579.58

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :25641-18-3
Fórmula molecular:C28H18N3NaO6S2
Punto de fusión:-
Código de sonrisas:[Na].[O-]S(=O)(=O)C1=CC=C(NC2=CC3=C(N=C4C=CC=CC4=[N+]3C3=CC=CC=C3)C3=C2C=C(C=C3)S([O-])(=O)=O)C=C1
Densidad:
Número de catálogo:CM693660
Peso molecular:579.58
Punto de ebullición:
Nº Mdl:MFCD00042002
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Related Products